A potential problem for Pfizer Lipitor brand and their R&D activities‚ as well as their business in general‚ is the fact that Lipitor will soon lose its patent protection. The problem is that they do not have any suitable replacements for the revenue that will soon be lost due to the emergence of generic drugs following a branded drugs loss of patent protection. Their main source of revenue‚ Lipitor (sales of $10 billion last year)‚ will lose its patent protection in 2010. 4 Alternative/Suggested
Premium Marketing Competition Brand
Lipitor-X Product Launch Plan Pfizer Inc is the largest research based biomedical and pharmaceutical company in the world. Headquartered in New York‚ Pfizer has major research and development locations in England and the United States. Since its inception in 1849‚ the organization has remained dedicated to discovering and developing new and better ways to prevent and treat disease‚ while helping to improve health and well being for people around the world. In November‚ the Pfizer
Premium Marketing People's Republic of China Pharmaceutical industry
“Strategic marketing focuses on choosing the right products for the right growth markets at the right time” (Jain & Haley‚ 2009‚ p. 26). When Lipitor hit the market in 1997 that is just what it achieved – the right product‚ the right growth market‚ and the right time. Lipitor quickly gained the No. 2 spot with 18% of the market share within the first year that led the way to gain the top spot as the market share leader. Warner-Lambert developed the drug initially but needed to catch up in
Premium Clinical trial Marketing Pharmaceutical industry
IMPACT OF LIPITOR PATENT EXPIRY ON PFIZER. TABLE OF CONTENTS PAGE NO Executive Summary 3 CHAPTER 1: INTRODUCTION 1.1 Introduction 4 1.2 What is Lipitor 5 1.3Expiry of Lipitor patent 5-6 CHAPTER 2: CHALLENGERS 2.1 Challengers 6 2.2 Pfizer’s strategies 7 CHAPTER 3:FINANCIAL IMPACT ON PFIZER AS LIPITOR GOES GENERIC 8-9 Recommendations 10 Conclusion 11 Executive summary: This
Premium Generic drug Pharmaceutical industry Food and Drug Administration
2012/1/31 Pfizer’s Lipitor new strategy for patent expired NTU EMBA 100B Paul‚ Wai-Hou Chan 陳惠濠 Table of Contents I. Introduction II. About Lipitor (Atorvastatin) III. Pfizer’s strategy IV. Patients seem to benefit from Pfizer’s new strategy V. Potentially profitable for retailers VI. Pfizer after Lipitor VII. Is Pfizer’s Lipitor strategy working? VIII. Wholesaler Profits: Brand vs. Generic drug IX. Pfizer is hoping to sell Lipitor to consumers over the
Premium Generic drug Food and Drug Administration Pharmaceutical industry
of Merger and acquisition Access to global market Gain economies of scale and access to new technologies. Economies of scale (buying in bulk‚ technology‚ specialization-cost adv) Acquisition of Warner Lambert gave Pfizer full marketing rights to Lipitor Acquisition of Pharmacia took Pfizer from number 4 in Europe and number 3 in Japan to number 1 globally Merge with Wyeth (access to technology in biologics and vaccines) -Strong R&D departments Merger with Wyeth and acquisition of
Premium Food and Drug Administration Pharmaceutical industry Pharmacology
References: Figure 1. Adapt from Hajak (2001‚ pp. 49 - 56) In general‚ residents in the UK are now suffering sky-high levels of insomnia University of Michinigan Business School (1999)‚ ‘Lipitor at heart of warner-lambet’‚ University of Michinigan Business School < http://www-personal.umich.edu/~afuah/cases/case26.pdf>
Premium Sleep Insomnia Sleep deprivation
At the time particularly Mevacor and Zocor hit the market‚ Lipitor just syinthesized by Warner-Lambert and it was still done animal testing or in the other words Lipitor is still developed become great statin in the world. To give alternative solution for the problem number one‚ Lipitor should understand about concept of planning and strategy and arrange suitable planning and strategy with the condition nowadays. Because the Lipitor still beginner. Starting a new business is not an easy matter
Premium Marketing Strategic management Sales
2013. Second‚ successful new prescription drugs can be extraordinarily profitable. Lipitor‚ the cholesterol-lowering drug sold by Pfizer‚ was introduced in 1997‚ and by 2006 this drug had generated a staggering $12.5 billion in annual sales for Pfizer. The costs of manufacturing‚ packing‚ and distributing Lipitor amounted to only about 10 percent of revenues. Pfizer spent close to $500 million on promoting Lipitor and perhaps as much again on maintaining a sales force to sell the product.
Premium Pharmacology Generic drug Pharmaceutical industry
Saddle River‚ NJ: Pearson Retrieved from the University of Phoenix eBook collection database. Pub Med Health (2012). Levothyroxine. Retrieved from www.ncbi.nlm.gov/pubmedhealth/PMH0000684/ RxList: The internet drug list (2012). Lipitor. Retrieved from www.rxlist.com/lipitor-drug.htm
Premium Trademark Brand Product management